Healthcare - Biotechnology - NASDAQ - US
$ 9.17
-12.6 %
$ 626 M
Market Cap
-4.61
P/E
INCOME STATEMENT
46 M
REVENUE
-73.7 M
OPERATING INCOME
-70.8 M
NET INCOME
EFFICIENCY
Earnings Waterfall
EyePoint Pharmaceuticals, Inc.
| Revenue | 46 M |
| Cost Of Revenue | 4.63 M |
| Gross Profit | 41.4 M |
| Operating Expenses | 116 M |
| Operating Income | -73.7 M |
| Other Expenses | -2.87 M |
| Net Income | -70.8 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Jun-2018 | Jun-2017 | Jun-2016 | Jun-2015 | Jun-2014 | Jun-2013 | Jun-2012 | Jun-2011 | Jun-2010 | Jun-2009 | Jun-2008 | Jun-2007 | Jun-2006 | Jun-2005 | Jun-2004 | Jun-2003 | Jun-2002 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||||||
| Revenue | 46.0 | 41.4 | 36.9 | 34.4 | 20.4 | 3.0 | 7.5 | 1.6 | 26.6 | 3.5 | 2.1 | 3.5 | 5.0 | 23.1 | 12.2 | 3.5 | 2.2 | 1.5 | 0.6 | 0.3 | 74.4 K | 0.5 |
| GROSS PROFIT | ||||||||||||||||||||||
| Cost Of Revenue | 4.6 | 8.3 | 8.2 | 5.8 | 2.7 | 18.5 | 0 | 0.8 | 14.4 | 78 K | 9.6 | 7.0 | 7.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 41.4 | 33.1 | 28.8 | 28.6 | 17.7 | (15.5) | 7.5 | 0.8 | 12.2 | 3.4 | (7.4) | (3.5) | (2.1) | 23.1 | 12.2 | 3.5 | 2.2 | 1.5 | 0.6 | 0.3 | 74.4 K | 0.5 |
| OPERATING INCOME | ||||||||||||||||||||||
| Operating Expenses | 116.5 | 112.0 | 84.0 | 65.9 | 65.5 | 29.2 | 26.1 | 23.4 | 20.1 | 17.0 | 14.2 | 13.9 | 15.0 | 14.0 | 16.8 | 28.4 | 37.8 | 29.1 | 10.9 | 6.5 | 3.7 | 1.8 |
| Selling, General and Administrative Expenses | 51.8 | 60.3 | 53.1 | 46.0 | 47.7 | 13.1 | 11.2 | 9.0 | 8.1 | 7.5 | 7.2 | 6.9 | 8.1 | 7.0 | 8.8 | 14.0 | 13.0 | 15.9 | 3.8 | 1.6 | 0.6 | 0 |
| Research and Development Expenses | 64.7 | 49.6 | 28.5 | 17.4 | 15.4 | 16.2 | 14.9 | 14.4 | 12.1 | 9.6 | 7.0 | 7.0 | 6.9 | 7.0 | 8.0 | 14.4 | 20.0 | 11.7 | 6.3 | 4.9 | 3.1 | 1.8 |
| Operating Income | (73.7) | (78.9) | (55.3) | (37.3) | (47.9) | (26.3) | (18.6) | (21.8) | 6.4 | (13.5) | (12.0) | (25.2) | (10.0) | 9.1 | (4.6) | (24.9) | (35.5) | (27.7) | (10.3) | (6.2) | (3.6) | (1.8) |
| PRE-TAX INCOME | ||||||||||||||||||||||
| Interest Income Expense | 1.2 | 3.2 | 5.5 | 7.3 | 6.2 | 0.7 | 0.7 | 0 | 0 | 1 K | 2 K | 0 | 1 K | 13 K | 0 | 0.5 | 1.9 | 3.4 | 3.4 | 3.92 K | 3.92 K | 0 |
| Total Other Income | 3.0 | (2.6) | (3.1) | (8.1) | (8.9) | (63.2) | (26.9) | 91 K | 72 K | 22 K | 5 K | 14 K | 0.2 | 1.2 | (0.3) | 1.2 | 8.9 | (61.2) | (17.7) | 9.3 | 807 | (1.8) |
| Pre-Tax Income | (70.7) | (102.3) | (58.4) | (45.4) | (56.8) | (53.2) | (18.5) | (21.7) | 6.4 | (13.5) | (12.0) | (25.0) | (8.8) | 8.8 | (3.5) | (76.2) | (127.2) | (28.0) | (11.5) | (5.2) | (3.6) | (2.3) |
| NET INCOME | ||||||||||||||||||||||
| Tax Provision | 83 K | 22.3 | 5.5 | 7.3 | 6.2 | (25.6) | (0.8) | (0.2) | 96 K | (0.1) | (0.1) | (0.2) | (0.2) | 23 K | (1.0) | (0.5) | (23.5) | (7.1) | (0.3) | (2.7) | (1.7) | (1.8) |
| Net Income | (70.8) | (124.5) | (63.9) | (52.7) | (63.0) | (53.2) | (18.5) | (21.5) | 6.3 | (13.4) | (11.9) | (24.8) | (8.6) | 8.8 | (2.5) | (75.7) | (103.7) | (20.9) | (11.2) | (2.6) | (1.9) | (2.3) |
| EPS | 1.82 | 3.34 | 2.22 | 4.1 | 6.04 | 11.5 | 5.23 | 6.81 | 2.16 | 4.87 | 5.16 | 11.9 | 4.43 | 4.76 | 1.37 | 41.6 | 93.9 | 27.8 | 21.5 | 0.84 | 7.32 | 5.48 |